PATENT CLAIM ANALYSIS

Application Number: 16100062
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "678000"]

Abstract:
The present invention provides methods for the treatment, amelioration, or prevention of a symptom of neuronal damage associated with cerebral ischemia comprising administering compositions comprising a compound of Formula I.

Claim (Index 16):
The method according to  claim 1 , wherein said composition is administered orally.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15411861', '14233734', '14850855', '16040281', '10667280']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7777530431064291
- 35 USC 102 Novelty (BERT): 0.5186632147387916
- Combined Prediction Score: 0.7518440602696653
- Mean Citation Score: 225.580152
- Max Citation Score: 226.47397
- Similarity Product: 116.68058152369858

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test